MCOVBS Stock Overview
Provides healthcare and diagnostic services in Poland, Sweden, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Medicover AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 132.80 |
| 52 Week High | SEK 187.20 |
| 52 Week Low | SEK 132.80 |
| Beta | 1.47 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -47.09% |
| 5 Year Change | 57.72% |
| Change since IPO | 117.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| MCOVBS | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.0% | -2.6% |
| 1Y | n/a | -25.9% | 2.7% |
Return vs Industry: Insufficient data to determine how MCOVBS performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how MCOVBS performed against the UK Market.
Price Volatility
| MCOVBS volatility | |
|---|---|
| MCOVBS Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: MCOVBS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MCOVBS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 45,316 | Fredrik Rågmark | www.medicover.com |
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.
Medicover AB (publ) Fundamentals Summary
| MCOVBS fundamental statistics | |
|---|---|
| Market cap | SEK 30.48b |
| Earnings (TTM) | SEK 260.58m |
| Revenue (TTM) | SEK 21.34b |
117.0x
P/E Ratio1.4x
P/S RatioIs MCOVBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCOVBS income statement (TTM) | |
|---|---|
| Revenue | €1.83b |
| Cost of Revenue | €1.45b |
| Gross Profit | €374.20m |
| Other Expenses | €351.90m |
| Earnings | €22.30m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 25, 2024
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 20.49% |
| Net Profit Margin | 1.22% |
| Debt/Equity Ratio | 112.3% |
How did MCOVBS perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield80%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/07/23 11:00 |
| End of Day Share Price | 2024/04/25 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medicover AB (publ) is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Lars Hevreng | Danske Bank |
| James Alexander Vane-Tempest | Jefferies LLC |